Special range for the handling of high-activity active substances taken in enterprise

New laboratory unit with sanofi aventisSanofi aventis ordered since short one in the research and development over a new laboratory range, in that high-activity active substances for the Pr�klinik to be processed can do � at one time of the drug development thus, in which over the characteristics of a substance and concomitantly over its potentially toxic effect already very much admits is, it however not yet in its later Darreichungsform and packing are present, in which it can be handled safe for patients and maintenance personnel. A typical example of such substances, for which special precautions and mechanisms are necessary, in order to avoid the contact with them, are active substances to treatment of Krebs.In the new laboratory areas, into which sanofi aventis more than one million euros invested, protect air-lock systems for humans and material the coworkers. The contact with the work property is avoided by insulators, glove interferences and other barriers. Filtering units provide besides within the entire laboratory range for negative pressure, so that no particles arrive outward. � in the highly developed work area the protection of individuals was the center of attention clearly �, explains Dr. Matthias Urmann, technical manager of the research & for us; Development of sanofi aventis of Germany, sees the new laboratories however likewise as profit for the F& E-location Frankfurt Dr. Norbert Lill to work on director/conductor of the department of Pharmaceutical Sciences Northern Europe, under whose scientific responsibility the new laboratory unit stands, in the meantime with its team already began, the first development project there: Teriflunomid. It restrains the Ver-mehrung of certain cells of the immune system and is � if all further investigations to positively run, for the treatment of patients with multiple sclerosis begin.

This text was translated automatically.